We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 46

Canada to change the regulation of “food-like" natural health products
  • Torys LLP
  • Canada
  • April 24 2012

On April 17, 2012, Health Canada announced that it will classify and transition all "food-like" natural health products (NHPs) to the regulatory framework that governs the sale of food products in Canada


Health Canada releases final guidance on subsequent entry biologics
  • Torys LLP
  • Canada
  • March 9 2010

Health Canada has released the final version of its guidance document Guidance for Sponsors: Information and Submission Requirements for Subsequent Entry Biologics (SEBs) (Final Guidance), which is an update of the draft guidance released by Health Canada on January 30, 2008 and March 27, 2009 and applies to all pending and future drug submissions for SEBs in Canada


More biopharma M&A in 2010, but healthy or distressed?
  • Torys LLP
  • Canada
  • December 31 2009

As blockbuster drugs began to come off patent, big pharmas fearing loss of revenue share rushed to couple with their counterparts in 2009


Canada’s PAAB releases updated Code of Advertising Acceptance
  • Torys LLP
  • Canada
  • December 7 2012

The Pharmaceutical Advertising Advisory Board (PAAB) has released a revised version of its Code of Advertising Acceptance


Producers to manage pharmaceuticals and sharps returned by consumers
  • Torys LLP
  • Canada
  • November 2 2012

On October 1, 2012, Collection of Pharmaceuticals and Sharps Responsibilities of Producers regulation (O. Reg. 29812) came into force


Amendments to the Patented Medicines (Notice of Compliance) Regulations now in force
  • Torys LLP
  • Canada
  • June 13 2008

On June 12, 2008, amendments to the Patented Medicines (Notice of Compliance) Regulations (commonly referred to as the “PM(NOC) Regulations”) came into force


Proposed amendments to the Patented Medicines (Notice of Compliance) Regulations
  • Torys LLP
  • Canada
  • April 29 2008

On April 26, 2008, the government of Canada published for comment proposed amendments to the Patented Medicines (Notice of Compliance) Regulations, commonly referred to as the “PM(NOC) Regulations.”


Canada proposes amending the Food and Drugs Act and creating consumer product safety legislation
  • Torys LLP
  • Canada
  • May 2 2008

On April 8, 2008, the federal government tabled legislation in the House of Commons to amend the Food and Drugs Act and to introduce new consumer product safety legislation in Canada


Follow-on biologics in Canada: a look at the new draft guidelines
  • Torys LLP
  • Canada
  • May 27 2008

Health Canada has released a draft guidance document entitled “Information and Submission Requirements for Subsequent Entry Biologics (SEBs).”


Ontario case on product liability shows the immense scope of a class action trial
  • Torys LLP
  • Canada
  • July 5 2012

In a highly anticipated decision released on June 26, 2012, the Ontario Superior Court of Justice ruled in favour of the defendants in Andersen v. St. Jude Medical, Inc., Ontario’s first medical product liability class action trial